Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: Positive association with non-fasting plasma triglyceride levels

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 86, Issue 1-2, 2012, Pages 71-77

  Hofacer, Rylon ^a   Jack Magrisso, I ^a   Jandacek, Ronald ^a   Rider, Therese ^a   Tso, Patrick ^a   Benoit, Stephen C ^a   McNamara, Robert K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Glucose; Liver; Omega 3 fatty acid; Rat; Stearoyl CoA desaturase 1 (Scd1); Triglyceride

Indexed keywords

GLUCOSE; INSULIN; LINOLENIC ACID; LONG CHAIN FATTY ACID; MESSENGER RNA; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DOWN REGULATION; FAT INTAKE; FATTY ACID ANALYSIS; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID COMPOSITION; LIPOGENESIS; LIVER LEVEL; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; OMEGA 3 FATTY ACID DEFICIENCY; OUTCOME ASSESSMENT; PERINATAL DEVELOPMENT; PERINATAL PERIOD; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SCD1 GENE; TRIACYLGLYCEROL BLOOD LEVEL;

ALPHA-LINOLENIC ACID; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; DIET; DOWN-REGULATION; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INSULIN; LIVER; MALE; POSTPRANDIAL PERIOD; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEAROYL-COA DESATURASE; TRIGLYCERIDES; WEANING;

RATTUS;

EID: 84155172153     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.10.003     Document Type: Article

References (43)

1. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk 1996, 3:213-219.
2. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. J. Am. Med. Assoc. 2007, 298:309-316.
3. Eberly L.E., Stamler J., Neaton J.D. Multiple risk factor intervention trial research group. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch. Intern. Med. 2003, 163:1077-1083.
4. Langsted A., Freiberg J.J., Nordestgaard B.G. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008, 118:2047-2056.
5. McKenney J.M., Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 2007, 27:715-728.
6. Skulas-Ray A.C., Kris-Etherton P.M., Harris W.S., Vanden Heuvel J.P., Wagner P.R., West S.G. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am. J. Clin. Nutr. 2011, 93:243-252.
7. Harris W.S., Kris-Etherton P.M., Harris K.A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr. Atheroscler. Rep. 2008, 10:503-509.
8. Lee J.H., O'Keefe J.H., Lavie C.J., Marchioli R., Harris W.S. Omega-3 fatty acids for cardioprotection. Mayo Clin. Proc. 2008, 83:324-332.
9. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J. Affect. Disord. 2010, 126:303-311.
10. T.C. Baghai, G. Varallo-Bedarida, C. Born, S. Häfner, C. Schüle, D. Eser, R. Rupprecht, B. Bondy, C. von Schacky, Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 index. J. Clin. Psychiatry. (2011) [Epub ahead of print].
11. Fiedorowicz J.G., Palagummi N.M., Forman-Hoffman V.L., Miller D.D., Haynes W.G. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann. Clin. Psychiatry 2008, 20:131-137.
12. Angst F., Stassen H.H., Clayton P.J., Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J. Affect. Disord. 2002, 68:167-181.
13. Paton C.M., Ntambi J.M. Biochemical and physiological function of stearoyl-CoA desaturase. Am. J. Physiol. Endocrinol. Metab. 2009, 297:28-37.
14. Miyazaki M., Kim Y.C., Gray-Keller M.P., Attie A.D., Ntambi J.M. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem. 2000, 275:30132-30138.
15. Miyazaki M., Kim Y.C., Ntambi J.M. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J. Lipid Res. 2001, 42:1018-1024.
16. Miyazaki M., Man W.C., Ntambi J.M. Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J. Nutr. 2001, 131:2260-2268.
17. Uto Y., Ogata T., Kiyotsuka Y., Ueno Y., Miyazawa Y., Kurata H., Deguchi T., Watanabe N., Konishi M., Okuyama R., Kurikawa N., Takagi T., Wakimoto S., Ohsumi J. Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl) amide and its plasma triglyceride-lowering effects in Zucker fatty rats. Bioorg. Med. Chem. Lett. 2010, 20:341-345.
18. Attie A.D., Krauss R.M., Gray-Keller M.P., Brownlie A., Miyazaki M., Kastelein J.J., Lusis A.J., Stalenhoef A.F., Stoehr J.P., Hayden M.R., Ntambi J.M. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 2002, 43:1899-1907.
19. Peter A., Cegan A., Wagner S., Lehmann R., Stefan N., Königsrainer A., Königsrainer I., Häring H.U., Schleicher E. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin. Chem. 2009, 55:2113-2120.
20. Landschulz K.T., Jump D.B., MacDougald O.A., Lane M.D. Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 1994, 200:763-768.
21. Ntambi J.M., Sessler A.M., Takova T. A model cell line to study regulation of stearoyl-CoA desaturase gene 1 expression by insulin and polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 1996, 220:990-995.
22. Sessler A.M., Kaur N., Palta J.P., Ntambi J.M. Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes. J. Biol. Chem. 1996, 271:29854-29858.
23. Garg M.L., Wierzbicki A.A., Thomson A.B., Clandinin M.T. Dietary cholesterol and/or n-3 fatty acid modulate delta 9-desaturase activity in rat liver microsomes. Biochim. Biophys. Acta 1988, 962:330-336.
24. Hassanali Z., Ametaj B.N., Field C.J., Proctor S.D., Vine D.F. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes. Metab. 2010, 12:139-147.
25. Lu J., Borthwick F., Hassanali Z., Wang Y., Mangat R., Ruth M., Shi D., Jaeschke A., Russell J.C., Field C.J., Proctor S.D., Vine D.F. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome. Br. J. Nutr. 2011, 31:1-11.
26. Mustad V.A., Demichele S., Huang Y.S., Mika A., Lubbers N., Berthiaume N., Polakowski J., Zinker B. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse. Metabolism 2006, 55:1365-1374.
27. Oarada M., Tsuzuki T., Gonoi T., Igarashi M., Kamei K., Nikawa T., Hirasaka K., Ogawa T., Miyazawa T., Nakagawa K., Kurita N. Effects of dietary fish oil on lipid peroxidation and serum triacylglycerol levels in psychologically stressed mice. Nutrition 2008, 24:67-75.
28. Qi K., Fan C., Jiang J., Zhu H., Jiao H., Meng Q., Deckelbaum R.J. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin. Nutr. 2008, 27:424-430.
29. Ryan A.S., Bailey-Hall E., Nelson E.B., Salem N. The hypolipidemic effect of an ethyl ester of algal-docosahexaenoic acid in rats fed a high-fructose diet. Lipids 2009, 44:817-826.
30. Kajikawa S., Harada T., Kawashima A., Imada K., Mizuguchi K. Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:229-238.
31. Igarashi M., Ma K., Chang L., Bell J.M., Rapoport S.I. Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J. Lipid Res. 2007, 48:2463-2470.
32. Issandou M., Bouillot A., Brusq J.M., Forest M.C., Grillot D., Guillard R., Martin S., Michiels C., Sulpice T., Daugan A. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models. Eur. J. Pharmacol. 2009, 618:28-36.
33. Rahman S.M., Dobrzyn A., Dobrzyn P., Lee S.H., Miyazaki M., Ntambi J.M. Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc. Natl. Acad. Sci. USA 2003, 100:11110-11115.
34. McNamara R.K., Able J.A., Liu Y., Jandacek R., Rider T., Tso P. Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition. Psychoneuroendocrinology 2009, 34:532-539.
35. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
36. Mutch D.M., Grigorov M., Berger A., Fay L.B., Roberts M.A., Watkins S.M., Williamson G., German J.B. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. FASEB J. 2005, 19:599-601.
37. Oguzhan B., Sancho V., Acitores A., Villanueva-Peñacarrillo M.L., Portois L., Chardigny J.M., Sener A., Carpentier Y.A., Malaisse W.J. Alteration of adipocyte metabolism in omega3 fatty acid-depleted rats. Horm. Metab. Res. 2006, 38:789-798.
38. Flowers M.T., Ntambi J.M. Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim. Biophys. Acta 2009, 1791:85-91.
39. Ntambi J.M., Miyazaki M., Stoehr J.P., Lan H., Kendziorski C.M., Yandell B.S., Song Y., Cohen P., Friedman J.M., Attie A.D. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA 2002, 99:11482-11486.
40. Pachikian B.D., Neyrinck A.M., Cani P.D., Portois L., Deldicque L., De Backer F.C., Bindels L.B., Sohet F.M., Malaisse W.J., Francaux M., Carpentier Y.A., Delzenne N.M. Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition. BMC Physiol. 2008, 8:21.
41. Nettleton J.A., Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J. Am. Diet. Assoc. 2005, 105:428-440.
42. Sampath H., Ntambi J.M. Role of stearoyl-CoA desaturase in human metabolic disease. Future Lipidology 2008, 3:163-173.
43. Waters K.M., Ntambi J.M. Polyunsaturated fatty acids inhibit hepatic stearoyl-CoA desaturase-1 gene in diabetic mice. Lipids 1996, 31(Suppl:S33-36).